Bryant Ranch Prepack FDA Inspection Record
Bryant Ranch Prepack is an FDA-registered facility (FEI 1000519407) located in Burbank, CA, US. Registered operations: RELABEL; REPACK. RegDataLab tracks 9 FDA inspections and 1 compliance action at this facility.
What FDA found at this site
- Latest inspection
- Jul 16, 2026: Voluntary Action Indicated (VAI)
- Inspections on record
- 9 (1 OAI, 8 VAI)
- Last OAI inspection
- Jun 11, 2009
- Warning letters
- 1 listed by FDA for this FEI, latest Apr 8, 2010
- Recalls as the recalling firm
- 8, latest May 10, 2024
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Jul 16, 2026 | Voluntary Action Indicated (VAI) | Defined areas of adequate size for operations (21 CFR 211.42(c)) Cleaning SOPs/equipment identification (21 CFR 211.67(b)(4)) Investigations of discrepancies, failures (21 CFR 211.192) Systems in place to comply with verification requirements (FDCA 582(b)(4)) |
| Jan 25, 2024 | Voluntary Action Indicated (VAI) | No citations listed |
| Mar 17, 2022 | Voluntary Action Indicated (VAI) | Cleaning / Sanitizing / Maintenance (21 CFR 211.67(a)) Procedures are written, and followed (21 CFR 211.130) Quarantine Storage of Components (21 CFR 211.82(b)) Annual visual exams of drug products (21 CFR 211.170(b)) and 1 more |
| Nov 18, 2019 | Voluntary Action Indicated (VAI) | Cleaning / Sanitizing / Maintenance (21 CFR 211.67(a)) Items to cover on annual reviews (21 CFR 211.180(e)(2)) Written record of investigation incomplete (21 CFR 211.192) |
| Dec 15, 2016 | Voluntary Action Indicated (VAI) | Written procedures not established/followed (21 CFR 211.67(b)) Calibration/Inspection/Checking not done (21 CFR 211.68(a)) Investigations of discrepancies, failures (21 CFR 211.192) Quarantine of Rejected Components et. al. (21 CFR 211.89) and 1 more |
| Jul 11, 2013 | Voluntary Action Indicated (VAI) | SOPs not followed / documented (21 CFR 211.100(b)) Responsible firm officials notified in writing (21 CFR 211.180(f)) Changes to Procedures Not Reviewed, Approved (21 CFR 211.100(a)) Annual visual exams of drug products (21 CFR 211.170(b)) |
| Jun 30, 2011 | Voluntary Action Indicated (VAI) | Calibration/Inspection/Checking not done (21 CFR 211.68(a)) SOPs not followed / documented (21 CFR 211.100(b)) Reprocessing procedures not written or followed (21 CFR 211.115(a)) Changes to Procedures Not Reviewed, Approved (21 CFR 211.100(a)) and 3 more |
| Sep 29, 2010 | Voluntary Action Indicated (VAI) | Cleaning / Sanitizing / Maintenance (21 CFR 211.67(a)) Rotation of components/containers/closures (21 CFR 211.86) Records reviewed annually (21 CFR 211.180(e)) Identification of new containers (21 CFR 211.101(b)) |
| Jun 11, 2009 | Official Action Indicated (OAI) | Buildings of Suitable Size, Construction, Location (21 CFR 211.42(a)) Lack of written stability program (21 CFR 211.166(a)) Complaint Investigation/Follow-Up Findings (21 CFR 211.198(b)(2)) Penicillin air handling systems not kept separate (21 CFR 211.46(d)) and 2 more |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| May 10, 2024 | Class III | D-0536-2024 | Cephalexin for Oral Suspension, USP, 125mg per 5mL, Rx only, 100 Tablets, Relabeled by… and 4 more products Labeling: Not Elsewhere Classified: Front label states 100 Tablets instead of 100 ml and on the back label 'Each Tablet contains'… |
| Apr 20, 2023 | Class III | D-0556-2023 | Lidocaine Patch 5%, 1 patch (63629-8755-20) packaged in 30-count patches per carton… Labeling: Typographical error on the upper left-hand side of the box and individual patch label that has the incorrect dosage form stating… |
| Jun 17, 2022 | Class I | D-1187-2022 | Morphine Sulfate extended-Release Tablets, USP; 30 mg, 100-count bottles, Rx only… and 1 more product Labeling: Label Mix-up: bottles labeled as Morphine Sulfate 60 mg Extended-Release tablets contain Morphine Sulfate 30 mg Extended-Release… |
| Oct 12, 2021 | Class I | D-0092-2022 | Methocarbamol 500mg Tablet, packaged in a) #30 count (NDC 7133517952), b) #60 count (NDC… Labeling: Label Error on Declared Strength; Bottles labeled as Methocarbamol 500 mg Tablets actually contain Methocarbamol 750 mg Tablets |
| Sep 28, 2021 | Class III | D-0256-2022 | Butalbital, APAP, Caf 50/325/40 Tablets, packaged in a) 12-count bottles, NDC… and 1 more product Labeling: Not Elsewhere Classified: the controlled substance classification "CIII" is missing on the label |
| Jan 27, 2021 | Class I | D-0303-2021 | Spironolactone Tablets, USP, 25 mg, packaged in: a) 30-count bottles (NDC 63629-1064-01)… and 1 more product Labeling: Label Mix-Up - Prepackaged bottles labeled spironolactone 25 mg may contain spironolactone 50 mg tablets. |
| Jul 27, 2018 | Class II | D-1027-2018 | Valsartan 80 mg tablets, 90-count bottles (NDC 63629-6922-2), 60-count bottles (… and 2 more products CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product. |
| Mar 25, 2016 | Class III | D-0837-2016 | Venlafaxine 75 mg Tablet, Compare to Effexor 75 mg Tablet, a) 30-count bottle (NDC… Labeling: Label Mix-Up: Bryant Ranch received Tevas venlafaxine hydrochloride extended-release tablets for repackaging, but labeled it… |
FDA record score
31 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
14 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Class I recall D-1187-2022, this FEI as the recalling firm | Jun 17, 2022 | 15 x 0.6 | 9 |
| Inspection classified VAI | Jul 16, 2026 | 6 x 1 | 6 |
| Class I recall D-0092-2022, this FEI as the recalling firm | Oct 12, 2021 | 15 x 0.25 | 3.8 |
| Class I recall D-0303-2021, this FEI as the recalling firm | Jan 27, 2021 | 15 x 0.25 | 3.8 |
| Inspection classified VAI | Jan 25, 2024 | 6 x 0.6 | 3.6 |
| Inspection classified VAI | Mar 17, 2022 | 6 x 0.6 | 3.6 |
| Class II recall D-1027-2018, this FEI as the recalling firm | Jul 27, 2018 | 4 x 0.25 | 1 |
| Inspection classified VAI | Nov 18, 2019 | Only the 3 most recent VAI inspections add points | 0 |
| Inspection classified VAI | Dec 15, 2016 | Only the 3 most recent VAI inspections add points | 0 |
| Inspection classified VAI | Jul 11, 2013 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Jun 30, 2011 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Sep 29, 2010 | 10 years or older, so it adds no points | 0 |
| Warning letter on FDA's dashboard, which does not show close-outs | Apr 8, 2010 | 10 years or older, so it adds no points | 0 |
| Inspection classified OAI | Jun 11, 2009 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Inspection citations | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 16, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 16, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 13, 2026 | Newest record Nov 12, 2026 | Current |
| Import refusals | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
Reviewing Bryant Ranch Prepack as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Bryant Ranch Prepack yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- Bryant Ranch PrePack
- Location
- Burbank, CA (US)
- Registration Expires
- Dec 31, 2027
- Operations
- RELABEL; REPACK
- Source
- decrs